Sarepta Therapeutics (SRPT) Treasury Shares (2010 - 2026)

Sarepta Therapeutics' Treasury Shares history runs 17 years deep, the most recent figure standing at $655642.0 for Q1 2026.

• In Q1 2026, Treasury Shares changed N/A year-over-year to $655642.0; the TTM figure through Mar 2026 stood at $655642.0 (changed N/A YoY), while the FY2025 annual figure was $650876.0, up 15.46% from the prior year.
• Treasury Shares was $25.3 million for Q1 2026 at Sarepta Therapeutics, roughly flat from $25.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.2 million in Q4 2023 to a low of -$651000.0 in Q2 2025.
• Historically, Treasury Shares has averaged $848609.3 across 5 years, with a median of $650876.0 in 2025.
• The sharpest annual moves came in 2022 and 2024: Treasury Shares soared 38.59% in 2022, then plunged 74.84% in 2024.
• A 2-year view of Treasury Shares shows it stood at $25.3 million in 2025, then changed by 0.0% to $25.3 million in 2026.
• The last three Treasury Shares figures came in at $25.3 million (Q1 2026), $25.3 million (Q4 2025), and $25.3 million (Q3 2025), per Business Quant data.